IP Library › Granted Patent US 7,160,727
Granted Patent B2
US 7,160,727 · App. 10/993,319 · Granted Jan 9, 2007

Methods for producing and using

Assignee: University of Iowa Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,160,727
App. No.
10/993,319
Granted
Jan 9, 2007
Kind
B2
Abstract

The present invention provides novel pseudotyped retroviral vectors that can transduce human and other cells. Vectors are provided that are packaged efficiently in packaging cells and cell lines to generate high titer recombinant virus stocks expressing novel envelope glycoproteins. The present invention further relates to compositions for gene therapy.

Claims (11)

1. A method for transducing a nervous system cell with a transgene comprising contacting the cell with a pseudotyped retrovirus virion comprising a Lymphocytic Choriomeningitis Virus strain WE-54 envelope glycoprotein and the transgene, wherein the envelope glycoprotein comprises a phenylalanine at residue 260.

2. A method for transducing a nervous system cell with a transgene comprising contacting the cell with a pseudotyped retrovirus virion comprising a Lymphocytic Choriomeningitis Virus strain WE-54 envelope glycoprotein and the transgene, wherein the envelope glycoprotein comprises a phenylalanine at residue 153.

3. The method of claim 1 , wherein the envelope glycoprotein further comprises a phenylalanine at residue 153.

4. The method of claim 1 , wherein said retrovirus virion is a lentivirus virion.

5. The method of claim 2 , wherein said retrovirus virion is a lentivirus virion.

6. The method of claim 4 , wherein said lentivirus virion is a feline immunodeficiency virus virion.

7. A method for transducing a nervous system cell with a transgene, said method comprising contacting the nervous system cell with a vector comprising (a) a nucleic acid encoding an envelope glycoprotein from Lymphocytic Choriomeningitis Virus strain WE-54, and (b) the transgene.

8. The method of claim 7 , wherein the envelope glycoprotein comprises a phenylalanine at residue 260.

9. The method of claim 7 , wherein the envelope glycoprotein comprises a phenylalanine at residue 153.

10. The method of claim 7 , wherein the envelope glycoprotein comprises a phenylalanine at residue 260 and a phenylalanine at residue 153.

11. The method of claim 4 , wherein said lentivirus virion is a feline immunodeficiency virus virion.

Assignments (2)
CONFIRMATORY LICENSE Recorded Oct 6, 2008
From: UNIVERSITY OF IOWA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021639/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2005
From: MCCRAY, PAUL B., JR.; DAVIDSON, BEVERLY L.; STEIN, COLLEEN
To: IOWA RESEARCH FOUNDATION, UNIVERSITY OF
Reel/Frame 015859/0222 →
Continuity (2)
Continuation In Part 1071826200 · Nov 20, 2003
Related Publication 20050123517A1 · Jun 9, 2005